Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jeroen J. W. M. Janssen
Satisfaction With Information on Nilotinib Treatment in Chronic Myeloid Leukemia Patients
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Related publications
Prognostic Value of Tumor Clones Early Reducation in Patients With Chronic Myeloid Leukemia on Nilotinib Treatment Who Failed Imatinib
Hematology & blood transfusion: interdepartamental collection
Development of Myasthenia Gravis in a Patient With Chronic Myeloid Leukemia During Treatment With Nilotinib
Hematology Reports
Hematology
Pancreatic Enzyme Elevation in Chronic Myeloid Leukemia Patients Treated With Nilotinib After Imatinib Failure
Haematologica
Hematology
Nilotinib for the Treatment of Chronic Myeloid Leukemia: An Evidence-Based Review
Core Evidence
Medicine
Reviews
References
Pharmacology
Therapeutic Drug Monitoring of Imatinib, Nilotinib, and Dasatinib for Patients With Chronic Myeloid Leukemia
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Nilotinib vs Imatinib in Patients With Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase: ENESTnd 3-Year Follow-Up
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Nilotinib Interferes With Cell Cycle, ABC Transporters and JAK-STAT Signaling Pathway in CD34+/lin- Cells of Patients With Chronic Phase Chronic Myeloid Leukemia After 12 Months of Treatment
PLoS ONE
Multidisciplinary
Budget Impact Analysis or Pharmacological Therapy of Chronic Myeloid Leukemia (Cml) With Nilotinib as the Second-Line Treatment in Russian Federation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Telomere Length Shortening Is Associated With Treatment-Free Remission in Chronic Myeloid Leukemia Patients
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
